Q-omics provides the consensus-scored LINC01949 profile across patient tissues and cancer cell-line models. Additionally, LINC01949 RNA expression shows 5,304 significant protein co-abundance associations, with the highest sampling consensus in GBM.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for LINC01949 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with LINC01949 in patient tissues and cancer cell lines. In patient samples, LINC01949 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set. In cancer cell lines, LINC01949 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LUNG_NSCLC_LUAD, while CRISPR and shRNA rows add functional-dependency signals in NCI60_ALL.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	5,304	GBM (1367)	view →
Function (mass-spec)	346	OV (115)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
RNA	1,271	LUNG_NSCLC_LUAD (274)	view →
shRNA	1,130	LUNG_NSCLC_LUAD (227)	view →
▼RNA
Inducing drug	2	NCI60_ALL (2)	view →